| Q26996418 | A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation |
| Q40234780 | A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus |
| Q49157618 | A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults |
| Q35081168 | A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients |
| Q41078474 | A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network |
| Q33796667 | Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly |
| Q36583285 | An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis |
| Q38286153 | Autophagosome formation during varicella-zoster virus infection following endoplasmic reticulum stress and the unfolded protein response |
| Q41909025 | Autophagy and the effects of its inhibition on varicella-zoster virus glycoprotein biosynthesis and infectivity |
| Q45757007 | B-cell epitopes of varicella-zoster virus glycoprotein II. |
| Q54216748 | Breadth and functionality of varicella zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans. |
| Q42415994 | COMMENTARY: Significantly less anti-gC antibody detectable in sera collected after varicella vaccination than after the disease varicella |
| Q45762764 | Characterization and expression of the Marek's disease virus serotype 2 glycoprotein E in recombinant baculovirus-infected cells: initial analysis of its DNA sequence and antigenic properties |
| Q41433631 | Cloning, expression and characterization of gE protein of duck plague virus |
| Q39642417 | Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. |
| Q37033241 | Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry |
| Q43161154 | Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts |
| Q42573780 | Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles |
| Q39879505 | Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. |
| Q27321449 | Exocytosis of Varicella-Zoster Virus Virions Involves a Convergence of Endosomal and Autophagy Pathways |
| Q36699001 | Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen |
| Q40781281 | Expression of the simian varicella virus glycoprotein E. |
| Q40843597 | Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells |
| Q39753125 | Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells |
| Q42011253 | Herpes simplex virus type 1 capsids transit by the trans-Golgi network, where viral glycoproteins accumulate independently of capsid egress. |
| Q59359552 | Herpes zoster subunit vaccine for the prevention of herpes zoster |
| Q33802787 | Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment |
| Q40046272 | Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. |
| Q45733660 | Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation |
| Q39782339 | Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum. |
| Q33639421 | Intracellular traffic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization. |
| Q37932527 | Molecular studies of the Oka varicella vaccine |
| Q35874201 | Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. |
| Q39882103 | Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking |
| Q41150988 | New varicella vaccines |
| Q40757793 | Non-clinical safety assessment of single and repeated administration of gE/AS01 zoster vaccine in rabbits. |
| Q35857312 | Productive varicella-zoster virus infection of cultured intact human ganglia |
| Q39698466 | Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo |
| Q101354739 | Pseudorabies virus glycoprotein gE suppresses interferon-β production via CREB-binding protein degradation |
| Q40065898 | Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI |
| Q36473935 | Role of PACS-1 in Trafficking of Human Cytomegalovirus Glycoprotein B and Virus Production |
| Q33783881 | Role of envelope protein gE endocytosis in the pseudorabies virus life cycle |
| Q37472498 | Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): a phase-I, open-label study in Japanese adults |
| Q42279944 | Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age. |
| Q38945231 | Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study |
| Q42688553 | The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes |
| Q36276500 | The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation |
| Q45729323 | The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades |
| Q39592132 | Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain |
| Q33845170 | Tyrosine phosphorylation of bovine herpesvirus 1 tegument protein VP22 correlates with the incorporation of VP22 into virions |
| Q40038098 | Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex). |
| Q40278402 | Varicella |
| Q39214502 | Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis |
| Q28076761 | Varicella-Zoster Virus Infectious Cycle: ER Stress, Autophagic Flux, and Amphisome-Mediated Trafficking |
| Q39604242 | Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression |
| Q33641265 | Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase |
| Q35874716 | Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms |
| Q35892356 | Varicella-zoster virus glycoprotein I is essential for growth of virus in Vero cells. |
| Q36639428 | Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system |
| Q41150916 | Varicella-zoster virus. The virus |
| Q24647289 | Viral infection and human disease--insights from minimotifs |